|
× |
 |
Associations of Leisure-Time and Occupational Physical Activity and Cardiorespiratory Fitness With Incident and Recurrent Major Depressive Disorder, Depressive Symptoms, and Incident Anxiety in a General Population PDF |
$40.00 |
|
$40.00 |
|
× |
|
The Use of Statins After a Cardiac Intervention Is Associated With Reduced Risk of Subsequent Depression: Proof of Concept for the Inflammatory and Oxidative Hypotheses of Depression? PDF |
$40.00 |
|
$40.00 |
|
× |
|
Impact of Physician Counseling and Perception of Teratogenic Risks: A Survey of 96 Nonpregnant Women With Anxiety PDF |
$40.00 |
|
$40.00 |
|
× |
|
Effectiveness and Safety of Vagus Nerve Stimulation for Severe Treatment-Resistant Major Depression in Clinical Practice After FDA Approval: Outcomes at 1 Year PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of Varenicline for Smoking Cessation in Patients With Schizophrenia or Schizoaffective Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Insomnia and Objectively Measured Sleep Disturbances Predict Treatment Outcome in Depressed Patients Treated With Psychotherapy or Psychotherapy-Pharmacotherapy Combinations PDF |
$40.00 |
|
$40.00 |
|
× |
|
Long-Term, Open-Label Study of the Safety and Efficacy of Atomoxetine in Adults With Attention-Deficit/Hyperactivity Disorder: An Interim Analysis PDF |
$40.00 |
|
$40.00 |
|
× |
|
A Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Quetiapine or Lithium as Monotherapy for Mania in Bipolar Disorder PDF |
$40.00 |
|
$40.00 |
|
× |
|
Violent Behavior and DSM-IV Psychiatric Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF |
$40.00 |
|
$40.00 |
|
× |
|
Long-Term Nonprescription Use of Dexamethasone and Cyproheptadine With Metabolic and Endocrine Sequelae PDF |
$40.00 |
|
$40.00 |
|
× |
|
Gender Differences in Generalized Anxiety Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) PDF |
$40.00 |
|
$40.00 |
|
× |
|
Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison PDF |
$40.00 |
|
$40.00 |
|
× |
|
Aripiprazole for the Management of Antipsychotic-Induced Hyperprolactinemia: A Retrospective Case Series PDF |
$40.00 |
|
$40.00 |
|
|
